For past 5 years, domestic companies suffer while multinational ones cruise

Domestic pharmaceutical companies were known to record slow performances in EDI for the past 5 years.

On the other hand, multinational pharmaceutical companies generally had high performances; for example, Pfizer kept the top performance position for 4 consecutive years from the year of 2012. Boehringer Ingelheim and Gilead, having a partner named Yuhan Corporation, showed outstanding growths ...